Clinical Research Training Institute

The ASH Clinical Research Training Institute (CRTI) is a unique, year-long education and mentoring program for hematology fellows and junior faculty at academic medical centers. CRTI offers a broad education on clinical research methods, research collaborations, statistical analysis, and the management of career and family demands. Its goal is to develop future leaders in clinical hematology by equipping participants with the knowledge, skills, and resources needed to transform innovative research ideas into successful, practice-changing studies.

Program Overview

Each year, 28 awardees (14 malignant hematology-focused awardees and 14 classical hematology-focused awardees) are selected to participate in the prestigious and rigorous training program led by faculty who are leaders in hematology. CRTI consists of four mandatory components:

  1. A week-long intensive workshop in August 2027 in La Jolla, California, which focuses on the foundation, methodologies, and application of patient-oriented clinical research
  2. A meeting at the ASH annual meeting in December 2027
  3. A one-day class in May 2028 at ASH Headquarters in Washington, DC
  4. Networking, mentorship, and education through distance learning, which takes place between the in-person meetings.
See Full Program Overview

Did you know? CRTI has Global Programs, too!

ASH offers condensed CRTI programs for international hematologists throughout the year. Learn more about each region, including their respective eligibility and application details.

Key Information

Eligibility Requirements

Applicants must be trainees or early-career faculty with a commitment to hematology or blood-related research.

See Additional Eligibility Requirements

Home Mentor Expectations

The support of home mentors are a valuable component not only to the participant, but also to the program. 

See Full Details

Research Project Requirements

Completion of a research proposal within the year of CRTI is not necessary, but applicants must have a clear plan for the timeline of the study and data analysis.

See Full Project Requirements

Application Process

The CRTI application, including supporting documents, must be submitted through the ASH online awards portal.

See All Application Steps

Evaluation, Selection, and Notification

Finalists selected to participate in CRTI will be notified in June and will receive a written review and critique of their proposal.

See All Evaluation Criteria

Terms and Conditions

As a condition of acceptance to CRTI you must maintain ASH membership throughout the duration of the program (from the time the LOI is due through the final project update meeting), and you must adhere to all required deadlines.

See All Terms and Conditions

Key Dates

Letter of Intent AvailableOctober 1, 2026
Letter of Intent Deadline (new deadline!)December 17, 2026 by 11:59 p.m. Eastern time
Candidates Invited to Submit Full ApplicationJanuary 11, 2027 
Application Deadline (for invited LOI's)March 4, 2027 at 11:59 p.m. Eastern time
Award Decision AnnouncedEnd of May 2027

Critiques available by End of June 2027
Virtual Kick-Off ProgrammingJune to July 2027 
WorkshopJuly 31 to August 6, 2027
Meeting at the ASH Annual Meeting December 2027
Final Class MeetingMay 2028 

What Is CRTI and What Makes It Unique?

Watch the video below to learn more about the ASH Clinical Research Training Institute, which provides essential training for the next generation of clinical hematology researchers.

See Past Participants

Questions?

If you have questions or require additional information regarding the ASH Clinical Research Training Institute, please contact training@hematology.org.

Never miss an important deadline—sign up to receive email updates about ASH awards and training programs.

Get email updates
Advocacy

An Unprecedented Investment

In response to ongoing threats to federal funding of hematology research and resources, since 2025 ASH has more than doubled its level of support for awards, career development opportunities, and mentorship programs to nearly $50 million, supporting 3,500+ awards. This investment includes an additional $25 million that goes far above and beyond ASH’s traditional funding levels as part of the #Fight4Hematology campaign.